Tne Crystal Structure of the Human Carbonic Anhydrase II in Complex with a Fluorescent Inhibitor

File:2f14.jpg


2f14, resolution 1.71Å

Drag the structure with the mouse to rotate

OverviewOverview

The X-ray crystal structure of the fluorescent antitumor sulfonamide, carbonic anhydrase (CA, EC, 4.2.1.1) inhibitor, (4-sulfamoylphenylethyl)thioureido fluorescein (1) in complex with the, cytosolic isoform hCA II is reported, together with a modeling study of, the adduct of 1 with the tumor-associated isoform hCA IX. Its binding to, hCA II is similar to that of other benzesulfonamides, with the ionized, sulfonamide coordinated to the Zn2+ ion within the enzyme active site, and, also participating in a network of hydrogen bonds with residues Thr199 and, Glu106. The scaffold of 1 did not establish polar interactions within the, enzyme active site but made hydrophobic contacts (<4.5 A) with Gln92, Val121, Phe131, Val135, Leu198, Thr199, Thr200, and Pro202. The, substituted 3-carboxy-amino-phenyl functionality was at van der Waals, distance from Phe131, Gly132, and Val135. The bulky tricyclic fluorescein, moiety was located at the rim of the active site, on the protein surface, and strongly interacted with the alpha-helix formed by residues, Asp130-Val135. All these interactions were preserved in the hCA IX-1, adduct, but the carbonyl moiety of the fluorescein tail of 1 participates, in a strong hydrogen bond with the guanidine moiety of Arg130, an amino, acid characteristic of the hCA IX active site. This may account for the, roughly 2 times higher affinity of 1 for hCA IX over hCA II and may, explain why in vivo the compound specifically accumulates only in hypoxic, tumors overexpressing CA IX and not in the normal tissues. The compound is, in clinical studies as an imaging tool for acute hypoxic tumors.

DiseaseDisease

Known disease associated with this structure: Osteopetrosis, autosomal recessive 3, with renal tubular acidosis OMIM:[611492]

About this StructureAbout this Structure

2F14 is a Single protein structure of sequence from Homo sapiens with , , and as ligands. Active as Carbonate dehydratase, with EC number 4.2.1.1 Full crystallographic information is available from OCA.

ReferenceReference

Carbonic anhydrase inhibitors: X-ray and molecular modeling study for the interaction of a fluorescent antitumor sulfonamide with isozyme II and IX., Alterio V, Vitale RM, Monti SM, Pedone C, Scozzafava A, Cecchi A, De Simone G, Supuran CT, J Am Chem Soc. 2006 Jun 28;128(25):8329-35. PMID:16787097

Page seeded by OCA on Fri Feb 15 17:24:21 2008

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA